ACCESS HFSH REAGENT 33520

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-10-20 for ACCESS HFSH REAGENT 33520 manufactured by Beckman Coulter Ireland.

Event Text Entries

[57973201] The customer did not supply patient's date of birth and weight. There is no evidence that the access hfsh reagent was returned for evaluation. A beckman coulter (bec) field service engineer (fse) was not dispatched to the customer's site. The customer was advised to send the patient's sample to the beckman coulter complaint handling unit (chu) for evaluation. The marseilles chu received one (1) sample for investigation. The patient's sample was analyzed utilizing the access hfsh assay on the access 2 immunoassay system (serial number (b)(4)). The marseilles chu obtained one (1) elevated result and confirmed customer's results. Further testing of this sample, with blocker proteins, decreased the sample's signal causing a decrease in the access hfsh result by 66%, confirming the presence of a patient source interferent related to heterophile antibodies. In conclusion, the cause of the elevated access hfsh results is due to a patient source interferent related to heterophile antibodies.
Patient Sequence No: 1, Text Type: N, H10


[57973202] The customer reported obtaining repeatable elevated follicle stimulating hormone (access hfsh) results for one (1) patient involving the laboratory's unicel dxi 800 access immunoassay system (serial number (b)(4)) that were discordant to the patient's clinical file. The initial access hfsh result recovered above the assay's normal reference range. The customer reanalyzed the patient's sample several additional times (no precision provided) on the same laboratory's unicel dxi 800 access immunoassay system (serial number (b)(4)) and obtained elevated results recovering above the assay's normal reference range again. Due to these elevated access hfsh results, the patient underwent a stimulation test. There was no report of additional change to treatment in conjunction with this event. Calibrations, quality controls (qc) and system checks were performing within assay and instrument specifications. No hardware errors, flags or other assay issues were reported in conjunction with this event. The patient's sample was collected in a serum tube and was centrifuged at 3,000 rpm (rotations per minute) for ten (10) minutes at room temperature. No issues with sample integrity were reported by the customer.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9680746-2016-00004
MDR Report Key6043693
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-10-20
Date of Report2016-09-26
Date of Event2016-09-22
Date Mfgr Received2016-09-26
Device Manufacturer Date2015-12-09
Date Added to Maude2016-10-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. ANGELA KILIAN
Manufacturer Street1000 LAKE HAZELTINE DRIVE
Manufacturer CityCHASKA 55318
Manufacturer CountryUS
Manufacturer Postal55318
Manufacturer Phone9523681330
Manufacturer G1BECKMAN COULTER IRELAND
Manufacturer StreetMERVUE BUSINESS PARK
Manufacturer CityMERVUE, GALWAY,
Manufacturer CountryEI
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameACCESS HFSH REAGENT
Generic NameRADIOIMMUNOASSAY, FOLLICLE-STIMULATING HORMONE
Product CodeCGJ
Date Received2016-10-20
Model NumberNA
Catalog Number33520
Lot Number570257
Device Expiration Date2017-10-31
OperatorHEALTH PROFESSIONAL
Device Availability*
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerBECKMAN COULTER IRELAND
Manufacturer AddressMERVUE BUSINESS PARK MERVUE, GALWAY, EI


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2016-10-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.